The study and its comparison
Forty-two overweight women reporting carbohydrate cravings completed a masked trial of chromium picolinate or placebo. The full paper specifies 1,000 micrograms of chromium daily; a milligram figure in the indexed abstract is inconsistent with it. [1]
Measured food intake, hunger and fat cravings decreased relative to placebo. The body-weight comparison was a nonsignificant trend, with p=0.08. [1]
What the finding establishes
Selected volunteers and short follow-up limit generalization. Rat brain-injection experiments in the same paper do not establish how oral supplements work in humans. Pennington supported the research and Nutrition 21 supplied Chromax; full conflicts were not established. This is not a demonstrated sustained weight-loss treatment. [1]
A hypothetical distinction
Imagine appetite ratings fall without a significant weight difference. A weight-loss headline would overstate the result.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of Chromium Picolinate on Food Intake and Satiety - PMC
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.